Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « options »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
optional < options < oral  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]
Ident.Authors (with country if any)Title
000000 (2009) Susan P. Bruce [États-Unis]Recent Developments in the Treatment of Rheumatoid Arthritis
000050 (2011) Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru HaradaCase of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000095 (2009) Paul Emery ; Rhonda SiddallTocilizumab — IL‐6 inhibition for the treatment of rheumatoid arthritis
000172 (2011) Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis]Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation
000174 (2012) M. Gaubitz [Allemagne]Biologika 2012
000194 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
000195 (2010) Luciana Breda [Italie] ; Marianna Del Torto [Italie] ; Sara De Sanctis [Italie] ; Francesco Chiarelli [Italie]Biologics in children’s autoimmune disorders: efficacy and safety
000211 (2006) Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]Biologic therapies for inflammatory eye disease
000214 (2012) Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000239 (2012) S. Kleinert [Allemagne] ; H. P. Tony [Allemagne]Rheumatische Erkrankungen mit Erstmanifestation im mittleren Lebensalter
000279 (2010) Arnd Heiligenhaus [Allemagne] ; Stephan Thurau [Allemagne] ; Maren Hennig [Allemagne] ; Rafael S. Grajewski [Allemagne] ; Gerhild Wildner [Allemagne]Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease
000759 (2013) Till Sörensen [Allemagne] ; Ursula Schulte-Wrede [Allemagne] ; Silvia Pade [Allemagne] ; Heike Hirseland [Allemagne] ; Gerd Burmester [Allemagne] ; Andreas Radbruch [Allemagne] ; Andreas Grützkau [Allemagne] ; Thomas H Upl [Allemagne]A10.4 Automated and Standardised Analysis for High Dimensional Cytometric Data Provides New Options for Complex Cell-Associated Biomarker Screening
000849 (2011) Shauna Culshaw [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni] ; Foo Y. Liew [Royaume-Uni]What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?
000A64 (2010) Anna Bazs [Hongrie] ; Krisztina Sevcic [Hongrie] ; Ilonka Orbán [Hongrie] ; Gyula Po R [Hongrie] ; Zsolt Balogh [Hongrie] ; Emese Kiss [Hongrie]Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report
000A92 (2012) Afsha A. Topal [Inde] ; Rachita S. Dhurat [Inde]Scleroderma therapy: clinical overview of current trends and future perspective
000C78 (2012) A. D. Wagner [Allemagne]Nierenbeteiligung im Rahmen von Großgefäßvaskulitiden
000D23 (2012) Marinos C. Dalakas [États-Unis, Grèce]Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future
000E21 (2010) D. Meyer-Olson [Allemagne] ; K. Hoeper [Allemagne] ; R. E. Schmidt [Allemagne]Infektionskomplikationen unter Biologika-Therapie bei Patienten mit rheumatoider Arthritis
000E37 (2011) Meredith A. Atkinson [États-Unis] ; Colin T. White [Canada]Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist
000E67 (2009) Sonja Merkesdal [Allemagne] ; Timm Kirchhoff [Allemagne] ; Diane Wolka [Allemagne] ; Gunter Ladinek [Allemagne] ; Adrian Kielhorn [Suisse] ; Andrea Rubbert-Roth [Allemagne]Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure
000E69 (2012) Takashi Kageyama [Japon] ; Mika Komori [Japon] ; Katsuichi Miyamoto [Japon] ; Akihiko Ozaki [Japon] ; Toshihiko Suenaga [Japon] ; Ryosuke Takahashi [Japon] ; Susumu Kusunoki [Japon] ; Sadayuki Matsumoto [Japon] ; Takayuki Kondo [Japon]Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "options" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "options" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    options
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021